Public Sector Pension Investment Board Acquires 6,800 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Public Sector Pension Investment Board grew its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 15.1% in the third quarter, HoldingsChannel.com reports. The firm owned 51,854 shares of the medical instruments supplier’s stock after purchasing an additional 6,800 shares during the period. Public Sector Pension Investment Board’s holdings in ICU Medical were worth $9,449,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Victory Capital Management Inc. raised its position in ICU Medical by 2,966.3% in the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock valued at $16,844,000 after buying an additional 137,222 shares during the last quarter. Millennium Management LLC boosted its holdings in ICU Medical by 327.8% during the 2nd quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier’s stock worth $16,158,000 after acquiring an additional 104,264 shares during the last quarter. FMR LLC grew its stake in shares of ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock worth $18,968,000 after acquiring an additional 100,345 shares in the last quarter. Granite Investment Partners LLC purchased a new stake in shares of ICU Medical in the second quarter valued at about $10,650,000. Finally, F M Investments LLC bought a new position in shares of ICU Medical during the second quarter valued at about $10,175,000. Institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Jefferies Financial Group started coverage on shares of ICU Medical in a research note on Monday, October 14th. They issued a “hold” rating and a $183.00 price objective for the company. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. KeyCorp boosted their price objective on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. Raymond James lifted their target price on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research note on Thursday, September 12th. Finally, Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $173.00.

Insider Buying and Selling

In other news, Director David C. Greenberg sold 972 shares of ICU Medical stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total value of $153,682.92. Following the completion of the transaction, the director now owns 5,037 shares in the company, valued at $796,400.07. This trade represents a 16.18 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $18,665,666.78. This trade represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,364 shares of company stock valued at $6,876,478. 6.70% of the stock is owned by insiders.

ICU Medical Stock Performance

NASDAQ:ICUI opened at $163.96 on Friday. ICU Medical, Inc. has a 1 year low of $83.26 and a 1 year high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The business has a fifty day simple moving average of $174.85 and a two-hundred day simple moving average of $146.69. The company has a market capitalization of $4.01 billion, a P/E ratio of -35.88 and a beta of 0.66.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.